Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Oldrich Coufal"'
Autor:
Petr Burkon, Iveta Selingerova, Marek Slavik, Milos Holanek, Miroslav Vrzal, Oldrich Coufal, Katerina Polachova, Petr Muller, Pavel Slampa, Tomas Kazda
Publikováno v:
Radiation Oncology, Vol 19, Iss 1, Pp 1-12 (2024)
Abstract Background Accelerated partial breast irradiation (APBI) is an alternative breast-conserving therapy approach where radiation is delivered in less time compared to whole breast irradiation (WBI), resulting in improved patient convenience, le
Externí odkaz:
https://doaj.org/article/f81720923d934241aecdf5d1a2a69c26
Autor:
Oldrich Coufal
Publikováno v:
IEEE Access, Vol 10, Pp 87745-87753 (2022)
Part of electrical engineering is circuit theory, which includes methods for calculating steady and transient currents in a series RL circuit. Power systems are typically inductive and can be modeled with RL circuits. An RL circuit is formed by a rea
Externí odkaz:
https://doaj.org/article/6e0dc14b8aba4536a7d12f3cc159e0c8
Autor:
Milos Holanek, Iveta Selingerova, Pavel Fabian, Oldrich Coufal, Ondrej Zapletal, Katarina Petrakova, Tomas Kazda, Roman Hrstka, Alexandr Poprach, Maria Zvarikova, Ondrej Bilek, Marek Svoboda
Publikováno v:
Diagnostics, Vol 12, Iss 7, p 1740 (2022)
A residual cancer burden after neoadjuvant therapy (NAT) for breast cancer (BC) is associated with worse treatment outcomes compared to patients who achieved pathologic complete remission. This single-institutional retrospective study of 767 consecut
Externí odkaz:
https://doaj.org/article/683bdd4ed2e2407987165083b0d972a6
Autor:
Milos Holanek, Iveta Selingerova, Ondrej Bilek, Tomas Kazda, Pavel Fabian, Lenka Foretova, Maria Zvarikova, Radka Obermannova, Ivana Kolouskova, Oldrich Coufal, Katarina Petrakova, Marek Svoboda, Alexandr Poprach
Publikováno v:
Cancers, Vol 13, Iss 7, p 1586 (2021)
Pathological complete response (pCR) achievement is undoubtedly the essential goal of neoadjuvant therapy for breast cancer, directly affecting survival endpoints. This retrospective study of 237 triple-negative breast cancer (TNBC) patients with a m
Externí odkaz:
https://doaj.org/article/705e0daa58fc46d2bc23b87a1e6fe6d9
Autor:
Lucie Gabrielova, Iveta Selingerova, Jan Zatecky, Ondrej Zapletal, Petr Burkon, Milos Holanek, Oldrich Coufal
Publikováno v:
Clinical Breast Cancer.
Autor:
Iveta Selingerová, Tomas Kazda, Ivana Kolouskova, Katarína Petráková, Miloš Holánek, Oldrich Coufal, Ondrej Bilek, Radka Obermannova, Lenka Foretova, Pavel Fabian, Marek Svoboda, Alexandr Poprach, Mária Zvaríková
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1586, p 1586 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1586, p 1586 (2021)
Volume 13
Issue 7
Pathological complete response (pCR) achievement is undoubtedly the essential goal of neoadjuvant therapy for breast cancer, directly affecting survival endpoints. This retrospective study of 237 triple-negative breast cancer (TNBC) patients with a m
Publikováno v:
PLASMA PHYSICS AND TECHNOLOGY. 6:47-50
Results of measurements carried out on the fabricated experimental modular-type arc heater serve as input data for the designed simplified model of the intensively blasted electric arc burning in argon inside the cylindrical arc heater‘s anode chan
Autor:
Jan Žatecký, Oldřich Coufal, Ondřej Zapletal, Otakar Kubala, Markéta Kepičová, Adéla Faridová, Karel Rauš, Jiří Gatěk, Peter Kosáč, Matúš Peteja
Publikováno v:
World Journal of Surgical Oncology, Vol 21, Iss 1, Pp 1-9 (2023)
Abstract Background Targeted axillary dissection (TAD) is an established method for axillary staging in patients with breast cancer after neoadjuvant chemotherapy (NAC). TAD consists of sentinel lymph node biopsy and initially pathological lymph node
Externí odkaz:
https://doaj.org/article/c07e9437b48348bf9d1126f6f472d087
Autor:
Eva Ondrouskova, Roman Hrstka, Lucia Sommerova, Rudolf Nenutil, Pavel Bouchal, Borivoj Vojtesek, Oldrich Coufal
Publikováno v:
Experimental and Molecular Pathology. 102:280-283
Expression of the AGR2 oncogene was shown to be associated with estrogen receptor positive tumors. This gene contributes to enhanced cellular proliferation, drug resistance, metastasis development and may also serve as a predictor of poor prognosis.